Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Total Current Liabilities (2020 - 2025)

Oncology Institute (TOI) has disclosed Total Current Liabilities for 6 consecutive years, with $65.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Total Current Liabilities changed N/A year-over-year to $65.6 million, compared with a TTM value of $65.6 million through Sep 2025, changed N/A, and an annual FY2024 reading of $52.2 million, up 50.09% over the prior year.
  • Total Current Liabilities was $65.6 million for Q3 2025 at Oncology Institute, up from $64.8 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $65.6 million in Q3 2025 and bottomed at $171572.0 in Q1 2021.
  • Average Total Current Liabilities over 5 years is $34.9 million, with a median of $33.8 million recorded in 2022.
  • The sharpest move saw Total Current Liabilities tumbled 56.11% in 2021, then skyrocketed 18271.88% in 2022.
  • Year by year, Total Current Liabilities stood at $29.8 million in 2021, then fell by 0.26% to $29.7 million in 2022, then grew by 17.05% to $34.8 million in 2023, then soared by 50.09% to $52.2 million in 2024, then grew by 25.6% to $65.6 million in 2025.
  • Business Quant data shows Total Current Liabilities for TOI at $65.6 million in Q3 2025, $64.8 million in Q2 2025, and $59.5 million in Q1 2025.